BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8736281)

  • 1. No mutation at codon 918 of the RET gene in a family with multiple endocrine neoplasia type 2B.
    Toogood AA; Eng C; Smith DP; Ponder BA; Shalet SM
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):759-62. PubMed ID: 8736281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature.
    Kahn MA; Cote GJ; Gagel RF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Sep; 82(3):288-94. PubMed ID: 8884827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.
    Gimm O; Marsh DJ; Andrew SD; Frilling A; Dahia PL; Mulligan LM; Zajac JD; Robinson BG; Eng C
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3902-4. PubMed ID: 9360560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of familial prominent corneal nerves and lesions of the tongue resembling neuromas to multiple endocrine neoplasia type 2B.
    Dennehy PJ; Feldman GL; Kambouris M; O'Malley ER; Sanders CY; Jackson CE
    Am J Ophthalmol; 1995 Oct; 120(4):456-61. PubMed ID: 7573303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families.
    Rossel M; Schuffenecker I; Schlumberger M; Bonnardel C; Modigliani E; Gardet P; Navarro J; Luo Y; Romeo G; Lenoir G
    Hum Genet; 1995 Apr; 95(4):403-6. PubMed ID: 7705835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.
    Miyauchi A; Futami H; Hai N; Yokozawa T; Kuma K; Aoki N; Kosugi S; Sugano K; Yamaguchi K
    Jpn J Cancer Res; 1999 Jan; 90(1):1-5. PubMed ID: 10076558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo RET proto-oncogene mutation in a patient with multiple endocrine neoplasia type 2B.
    Chang TJ; Wu SL; Chang TC; Huang SH; Chang TJ
    J Formos Med Assoc; 1999 Oct; 98(10):692-7. PubMed ID: 10575840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
    Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
    Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
    Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
    Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain.
    Sánchez B; Robledo M; Biarnes J; Sáez ME; Volpini V; Benítez J; Navarro E; Ruiz A; Antiñolo G; Borrego S
    J Med Genet; 1999 Jan; 36(1):68-70. PubMed ID: 9950371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
    Acton DS; Velthuyzen D; Lips CJ; Höppener JW
    Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia 2B with glaucoma associated with codon 918 mutation of the RET proto-oncogene.
    Mashima Y; Konishi M; Yamada M; Imamura Y; Nii S; Nakamura Y
    Acta Ophthalmol Scand; 1998 Feb; 76(1):114-6. PubMed ID: 9541448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutation of RET codon 883 in two cases of de novo MEN 2B.
    Smith DP; Houghton C; Ponder BA
    Oncogene; 1997 Sep; 15(10):1213-7. PubMed ID: 9294615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.
    Iwashita T; Murakami H; Kurokawa K; Kawai K; Miyauchi A; Futami H; Qiao S; Ichihara M; Takahashi M
    Biochem Biophys Res Commun; 2000 Feb; 268(3):804-8. PubMed ID: 10679286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.